In very severe myelosuppression, which occurs in some regimens, almost all the bone marrow stem cells ( cells that produce bone marrow cell transplants are necessary . ( In autologous BMTs, cells are removed from the patient before the treatment, multiplied and then re-injected afterward; in " allogenic"
32.
As of November 2013, researchers at the Seoul National University Hospital will be looking to recruit participants into a clinical trial to evaluate the efficacy of allogenic adipose-derived mesenchymal stem cells ( ALLO-ASC ) for the treatment of a lateral epicondylitis tendon injury where the duration of the symptoms is over six months.
